1. Home
  2. AMPH vs VYX Comparison

AMPH vs VYX Comparison

Compare AMPH & VYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • VYX
  • Stock Information
  • Founded
  • AMPH 1996
  • VYX 1881
  • Country
  • AMPH United States
  • VYX United States
  • Employees
  • AMPH N/A
  • VYX N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • VYX
  • Sector
  • AMPH Health Care
  • VYX
  • Exchange
  • AMPH Nasdaq
  • VYX Nasdaq
  • Market Cap
  • AMPH 1.1B
  • VYX 1.2B
  • IPO Year
  • AMPH 2014
  • VYX N/A
  • Fundamental
  • Price
  • AMPH $23.30
  • VYX $10.89
  • Analyst Decision
  • AMPH Hold
  • VYX Strong Buy
  • Analyst Count
  • AMPH 5
  • VYX 6
  • Target Price
  • AMPH $38.00
  • VYX $14.83
  • AVG Volume (30 Days)
  • AMPH 566.0K
  • VYX 2.0M
  • Earning Date
  • AMPH 05-07-2025
  • VYX 05-08-2025
  • Dividend Yield
  • AMPH N/A
  • VYX N/A
  • EPS Growth
  • AMPH N/A
  • VYX N/A
  • EPS
  • AMPH 2.77
  • VYX 6.72
  • Revenue
  • AMPH $730,659,000.00
  • VYX $2,733,000,000.00
  • Revenue This Year
  • AMPH $1.48
  • VYX N/A
  • Revenue Next Year
  • AMPH $5.97
  • VYX N/A
  • P/E Ratio
  • AMPH $8.47
  • VYX $1.62
  • Revenue Growth
  • AMPH 8.05
  • VYX N/A
  • 52 Week Low
  • AMPH $22.64
  • VYX $7.55
  • 52 Week High
  • AMPH $53.96
  • VYX $15.34
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 39.25
  • VYX 69.96
  • Support Level
  • AMPH $23.30
  • VYX $8.55
  • Resistance Level
  • AMPH $25.36
  • VYX $11.29
  • Average True Range (ATR)
  • AMPH 0.86
  • VYX 0.35
  • MACD
  • AMPH 0.10
  • VYX 0.35
  • Stochastic Oscillator
  • AMPH 1.66
  • VYX 86.35

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

Share on Social Networks: